Browse

Drug substances

Substance records resolved from GSRS and FDA product data, linked to the trials and approvals that reference them.

120,974 results

SubstanceUNIIType
Influenza A Virus A/Massachusetts/18/2022 (H3N2) recombinant hemagglutinin antigenLC8M5WSW4Kprotein
Influenza A Virus A/West Virginia/30/2022 (H1N1) recombinant hemagglutinin antigenMGF6W7RFC8protein
Influenza A Virus A/West Virginia/30/2022 (H1N1) wholeB6G26T5GL4structurallyDiverse
Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) antigen (propiolactone inactivated)L38QVJ42SYstructurallyDiverse
Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) hemagglutinin antigen (propiolactone inactivated)R3KQM5Q4QFstructurallyDiverse
Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) neuraminidase antigen (propiolactone inactivated)Z83R4W7YJPstructurallyDiverse
Influenza A virus A/Darwin/1369/2025 (H3N2) whole62EM6CP7H3structurallyDiverse
Influenza A virus A/Darwin/1415/2025 (H3N2) wholeBTU7W6A6M9structurallyDiverse
Influenza A virus A/Guangdong/17SF003/2016 NIBRG-375 (H7N9) wholeK8NBE9CXJ5structurallyDiverse
Influenza A virus A/Switzerland/6849/2025 (H1N1) wholeZK6U5FTB5CstructurallyDiverse
Influenza A virus A/Tasmania/787/2025 CVR-388 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)GM63R2NZH7structurallyDiverse
Influenza A virus A/Tasmania/787/2025 CVR-388 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)4C76E8YD3TstructurallyDiverse
Influenza A virus A/Tasmania/787/2025 CVR-388 (H3N2) neuraminidase antigen (MDCK cell derived, propiolactone inactivated)B5PAV43R2AstructurallyDiverse
Influenza A virus A/Tasmania/787/2025 CVR-388 (H3N2) wholeEDN5WW92PBstructurallyDiverse
Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (propiolactone inactivated)PRE3ERF7G4structurallyDiverse
Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) hemagglutinin antigen (propiolactone inactivated)546N59ZB2SstructurallyDiverse
Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) neuraminidase antigen (propiolactone inactivated)ZSF4YM4PREstructurallyDiverse
Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) wholeARW72H8L6MstructurallyDiverse
Influenza A virus A/Victoria/800/2024 CVR-289 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)4HH5SUR63TstructurallyDiverse
Influenza A virus A/Victoria/800/2024 CVR-289 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)9V9Y969F8MstructurallyDiverse
Influenza A virus A/Victoria/800/2024 CVR-289 (H3N2) wholeR7C6GG83QDstructurallyDiverse
Influenza A virus H5N8 whole3CHE62XGB6structurallyDiverse
Influenza B virus B/Perth/115/2025 wholeK8XM32GS8WstructurallyDiverse
Influenza C virus whole2L4TEJ39E7structurallyDiverse
Inga edulis leafSSK68M7BJ5structurallyDiverse
Inga inicuil whole05216FYJ7HstructurallyDiverse
Inga vera wholeUC2GB5YA3FstructurallyDiverse
Ingitamig6R6GWJ8GDZprotein
Inidascamine3LW01V88B7chemical
Inidascamine dihydrochloride520S60B45Pchemical
Inidascamine tartrate1597R94F8Dchemical
InixaciclibQ6460P4C0Bchemical
InlecitugFA5YAU8H6Rprotein
InlexisertibJM2ZTM8S7Schemical
Inositol 1,3,4,5-tetraphosphateXK67P86535chemical
Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1T5J8YVL47Eprotein
InpegsomatropinNUB86ZJ8XTprotein
Inpegsomatropin-lysine PEG (40000 MW)8L5XUJ2R34polymer
Inpegsomatropin-phenylalanine PEG (40000 MW)93UC5FX8NUpolymer
Insulin DesanicHVQ5A42D44protein
Insulin EflivetC6834VZA9Aprotein
Insulin IcodecP7YU3ED05Nprotein
Insulin Ludefen2S3BP2LSQ2protein
Insulin aspart A21Asp impurityHQ86RPC3P5protein
Insulin aspart B28 isoaspartate impurityG8TU4YJ9SXprotein
Insulin aspart B3 isoaspartate impurityK3FB88WP6Kprotein
Insulin desanic C-terminal lysine modificationP4V95N8KM3chemical
Insulin gene enhancer protein ISL-1R54L3L2ZLVprotein
Insulin ludefen lysine modificaitonGR28J367R7chemical
IntegrinY8K9FD59TYchemical